Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Hereditary and environmental factors associated with risk and progression of head and neck cancer.

Trizna Z, Schantz SP.

Otolaryngol Clin North Am. 1992 Oct;25(5):1089-103. Review.

PMID:
1408193
2.

Genetic and environmental factors in head and neck cancer genesis.

Báez A.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Apr-Jun;26(2):174-200. doi: 10.1080/10590500802129431. Review.

PMID:
18569329
3.

[The effect of the microenvironment of head and neck cancers on tumor progression].

Lukits J.

Magy Onkol. 2009 Mar;53(1):51-9. doi: 10.1556/MOnkol.53.2009.1.8. Hungarian.

4.

[Cellular and neoplastic otorhinolaryngologic changes, molecular markers and therapeutic potential].

Blons H, Laccourreye O, Laurent-Puig P.

Ann Otolaryngol Chir Cervicofac. 2003 Jun;120(3):152-60. Review. French.

PMID:
12843984
5.

Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.

Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-Prado JC, Reis PM, de Freitas SE, Filho JF, Fukuyama EE, Cordeiro JA, Cury PM, Maniglia JV, Villa LL, Tajara EH, Rahal P.

Cancer Genet Cytogenet. 2004 Apr 1;150(1):44-9.

PMID:
15041222
7.

Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.

Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA.

Cancer Res. 1993 Apr 1;53(7):1676-83.

8.

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.

Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, Vokes EE, Weichselbaum RR.

Clin Cancer Res. 1996 Apr;2(4):755-62.

9.

Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma.

Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Hsu TC, Schantz SP.

Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1043-9.

10.

[Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].

Székely G, Remenár E, Kásler M, Bodrog A, Gundy S.

Orv Hetil. 2001 Mar 25;142(12):611-6. Hungarian.

PMID:
11324219
11.

Hereditary and environmental risk factors; clinical and laboratory risk matters for head and neck, especially oral, cancer and precancer.

Johnson NW, Warnakulasuriy S, Tavassoli M.

Eur J Cancer Prev. 1996 Feb;5(1):5-17. Review.

PMID:
8664810
12.

Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers.

Schantz SP, Huang Q, Shah K, Murty VV, Hsu TC, Yu G, Andersen PE, Huvos AG, Chaganti RS.

Carcinogenesis. 2000 Jun;21(6):1239-46.

PMID:
10837016
13.
14.
15.

Perspectives on the molecular epidemiology of aerodigestive tract cancers.

Hung RJ, van der Hel O, Tavtigian SV, Brennan P, Boffetta P, Hashibe M.

Mutat Res. 2005 Dec 30;592(1-2):102-18. Epub 2005 Jul 14. Review.

PMID:
16023150
16.
17.
18.

Applications of molecular epidemiology to head and neck cancer.

Hart TC.

Otolaryngol Clin North Am. 1997 Feb;30(1):21-34. Review.

PMID:
8995134
19.

Environmental and chemical carcinogenesis.

Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.

Semin Cancer Biol. 2004 Dec;14(6):473-86. Review.

PMID:
15489140
20.

ABCB1 genetic polymorphism and risk of upper aerodigestive tract cancers among smokers, tobacco chewers and alcoholics in an Indian population.

Sam SS, Thomas V, Sivagnanam K, Reddy KS, Surianarayanan G, Chandrasekaran A.

Pharmacogenet Genomics. 2007 Oct;17(10):861-6.

PMID:
17885624

Supplemental Content

Support Center